EXPLORE!

Concomitant glucocorticoids and PPI use increases fracture risk in RA patients

  751 Views

#Internal Medicine  #Orthopedics  #Pharmacist  #Rheumatology 

eMediNexus    25 February 2021

Rheumatoid arthritis (RA) patients treated with oral glucocorticoids and proton pump inhibitors (PPIs) had an elevated risk for osteoporotic fracture, reported a large cohort study published online in Annals of the Rheumatic Diseases.

Concomitant use of glucocorticoids and PPIs was found to be linked with a 1.6 times increased risk of osteoporotic fracture (adjusted HR 1.60, 95% CI 1.35-1.89), reported researchers. Use of either oral glucocorticoids or PPIs alone was associated with only a 1.2 times increased risk. 

For glucocorticoid alone, the adjusted hazard ratio was 1.23 (95% CI 1.03-1.47), and that for PPI use alone was 1.22 (95% CI 1.05-1.42). This was statistically lower than that for concomitant use of the two drugs… (Medpage Today)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.